Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program-Reference-Cited by-同舟云学术

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program

Published:1995-10 Issue:4 Volume:46 Page:445-461
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Barry Michael J.,Fleming Craig,Coley Christopher M.,Wasson John H.,Fahs Marianne C.,Oesterling Joseph E.

Publisher

Elsevier BV

Subject

Urology

Reference47 articles.

1. A decision analysis of alternative treatment strategies for clinically localized prostate cancer;Fleming;JAMA,1993

2. The benefit and cost of prostate cancer early detection;Littrup;CA Cancer J Clin,1993

3. Cost effectiveness of adding a prostate specific antigen test to digital rectal examination for early detection of prostate cancer (abstract 802);Simpson;J Urol,1993

4. Screening for prostate cancer: a decision analytic view;Krahn;JAMA,1994

5. A critique of the decision analysis for clinically localized prostate cancer.;Beck;J Urol,1994

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model;BMC Public Health;2017-06-26

2. The ONCOTYROL Prostate Cancer Outcome and Policy Model;Medical Decision Making;2015-05-14

3. Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data;JNCI: Journal of the National Cancer Institute;2014-12-13

4. A literature review of cost–effectiveness analyses of prostate-specific antigen test in prostate cancer screening;Expert Review of Pharmacoeconomics & Outcomes Research;2013-06

5. Strategies for early diagnosis and prevention of prostate cancer;B CANCER;2010